Showa Denko KK
TSE:4004
Showa Denko KK
TSE:4004
Price:
4 050
JPY
-1.2%
Market Closed
Market Cap:
731.9B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Showa Denko KK
4050
+16 (+0.4%)
| 52 Week Range |
2 632.5
4 218
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Showa Denko KK
Balance Sheet
Balance Sheet Decomposition
Showa Denko KK
Showa Denko KK
| Current Assets | 807.1B |
| Cash & Short-Term Investments | 243B |
| Receivables | 260.6B |
| Other Current Assets | 303.6B |
| Non-Current Assets | 1.3T |
| Long-Term Investments | 75.4B |
| PP&E | 681.1B |
| Intangibles | 435.7B |
| Other Non-Current Assets | 60.2B |
| Current Liabilities | 488.2B |
| Accounts Payable | 169.8B |
| Short-Term Debt | 59.9B |
| Other Current Liabilities | 258.5B |
| Non-Current Liabilities | 980.3B |
| Long-Term Debt | 841.8B |
| Other Non-Current Liabilities | 138.4B |
Balance Sheet
Showa Denko KK
Showa Denko KK
Currency: JPY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
66 840
|
64 054
|
69 914
|
77 248
|
113 186
|
122 086
|
198 982
|
236 237
|
187 287
|
190 318
|
|
| Cash Equivalents |
66 840
|
64 054
|
69 914
|
77 248
|
113 186
|
122 086
|
198 982
|
236 237
|
187 287
|
190 318
|
|
| Total Receivables |
155 371
|
134 197
|
143 117
|
173 172
|
202 344
|
169 539
|
270 536
|
277 215
|
264 839
|
264 391
|
|
| Accounts Receivables |
155 371
|
134 197
|
143 117
|
173 172
|
202 344
|
169 539
|
270 536
|
277 215
|
264 839
|
264 391
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
123 600
|
105 925
|
91 347
|
114 913
|
152 800
|
173 667
|
190 207
|
203 878
|
250 453
|
225 193
|
|
| Other Current Assets |
34 628
|
27 349
|
30 699
|
41 861
|
28 203
|
31 765
|
62 919
|
81 201
|
85 246
|
72 020
|
|
| Total Current Assets |
380 439
|
331 525
|
335 077
|
407 194
|
496 533
|
497 057
|
722 644
|
798 531
|
787 037
|
751 922
|
|
| PP&E Net |
513 656
|
502 293
|
487 135
|
505 933
|
478 406
|
473 168
|
727 119
|
659 521
|
678 064
|
678 586
|
|
| Intangible Assets |
11 700
|
12 268
|
11 712
|
12 817
|
14 950
|
22 650
|
239 243
|
210 723
|
198 334
|
185 390
|
|
| Goodwill |
1 980
|
0
|
0
|
0
|
0
|
0
|
359 200
|
311 766
|
295 355
|
285 199
|
|
| Long-Term Investments |
78 404
|
78 327
|
76 694
|
89 966
|
72 785
|
72 685
|
107 332
|
104 496
|
84 207
|
72 915
|
|
| Other Long-Term Assets |
24 904
|
16 081
|
22 080
|
11 089
|
12 309
|
10 821
|
48 068
|
57 353
|
50 747
|
57 941
|
|
| Other Assets |
1 980
|
0
|
0
|
0
|
0
|
0
|
359 200
|
311 766
|
295 355
|
285 199
|
|
| Total Assets |
1 011 083
N/A
|
940 494
-7%
|
932 698
-1%
|
1 026 999
+10%
|
1 074 983
+5%
|
1 076 381
+0%
|
2 203 606
+105%
|
2 142 390
-3%
|
2 093 744
-2%
|
2 031 953
-3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
127 206
|
103 737
|
104 005
|
120 762
|
139 420
|
117 510
|
164 356
|
207 745
|
194 054
|
177 375
|
|
| Accrued Liabilities |
2 135
|
1 904
|
2 253
|
2 949
|
3 516
|
3 050
|
8 815
|
8 886
|
9 536
|
10 702
|
|
| Short-Term Debt |
76 519
|
81 000
|
71 895
|
91 699
|
81 747
|
52 720
|
72 645
|
74 451
|
72 419
|
62 489
|
|
| Current Portion of Long-Term Debt |
125 448
|
103 714
|
91 069
|
93 618
|
73 383
|
35 794
|
67 263
|
83 868
|
85 631
|
105 539
|
|
| Other Current Liabilities |
49 473
|
40 738
|
41 570
|
62 807
|
64 008
|
53 801
|
98 992
|
113 700
|
97 237
|
105 776
|
|
| Total Current Liabilities |
380 781
|
331 093
|
310 792
|
371 835
|
362 074
|
262 875
|
412 071
|
488 650
|
458 877
|
461 881
|
|
| Long-Term Debt |
226 608
|
234 850
|
237 125
|
202 184
|
166 646
|
217 945
|
925 953
|
699 355
|
944 832
|
887 667
|
|
| Deferred Income Tax |
43 294
|
39 766
|
37 185
|
45 368
|
38 351
|
40 100
|
93 613
|
90 272
|
80 904
|
64 769
|
|
| Minority Interest |
20 333
|
11 629
|
14 671
|
16 524
|
19 377
|
20 067
|
312 119
|
304 463
|
24 423
|
25 830
|
|
| Other Liabilities |
39 896
|
26 643
|
36 365
|
38 618
|
42 572
|
36 028
|
53 889
|
45 661
|
34 413
|
38 968
|
|
| Total Liabilities |
710 912
N/A
|
643 981
-9%
|
636 138
-1%
|
674 529
+6%
|
629 020
-7%
|
577 015
-8%
|
1 797 645
+212%
|
1 628 401
-9%
|
1 543 449
-5%
|
1 479 115
-4%
|
|
| Equity | |||||||||||
| Common Stock |
140 564
|
140 564
|
140 564
|
140 564
|
140 564
|
140 564
|
140 564
|
182 146
|
182 146
|
182 146
|
|
| Retained Earnings |
57 467
|
55 202
|
65 358
|
100 076
|
197 717
|
249 246
|
165 572
|
143 335
|
165 902
|
137 269
|
|
| Additional Paid In Capital |
62 221
|
62 221
|
62 033
|
61 663
|
78 911
|
78 912
|
78 190
|
119 772
|
108 140
|
108 140
|
|
| Unrealized Security Profit/Loss |
34 691
|
35 234
|
35 545
|
46 088
|
40 770
|
42 849
|
32 762
|
31 766
|
28 270
|
26 307
|
|
| Treasury Stock |
10 153
|
10 157
|
10 502
|
10 503
|
11 659
|
11 664
|
11 657
|
11 655
|
11 612
|
11 593
|
|
| Other Equity |
15 381
|
13 449
|
3 562
|
14 582
|
340
|
541
|
530
|
48 625
|
77 449
|
110 569
|
|
| Total Equity |
300 171
N/A
|
296 513
-1%
|
296 560
+0%
|
352 470
+19%
|
445 963
+27%
|
499 366
+12%
|
405 961
-19%
|
513 989
+27%
|
550 295
+7%
|
552 838
+0%
|
|
| Total Liabilities & Equity |
1 011 083
N/A
|
940 494
-7%
|
932 698
-1%
|
1 026 999
+10%
|
1 074 983
+5%
|
1 076 381
+0%
|
2 203 606
+105%
|
2 142 390
-3%
|
2 093 744
-2%
|
2 031 953
-3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
143
|
143
|
143
|
143
|
146
|
146
|
146
|
181
|
181
|
181
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
